![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JA Beavo, M Conti and RJ Heaslip
Department of Pharmacology, University of Washington, Seattle 98195.
This article has been cited by other articles:
|
|
 |
|
  R M H Diederen, E C La Heij, M Markerink-van Ittersum, A Kijlstra, F Hendrikse, and J de Vente Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells Br. J. Ophthalmol., March 1, 2007; 91(3): 379 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-L. Wong, F. Whelan, P. Deloukas, P. Whittaker, M. Delgado, R. M. Cantor, S. M. McCann, and J. Licinio Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response PNAS, October 10, 2006; 103(41): 15124 - 15129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Bender and J. A. Beavo Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use Pharmacol. Rev., September 1, 2006; 58(3): 488 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gross-Langenhoff, K. Hofbauer, J. Weber, A. Schultz, and J. E. Schultz cAMP Is a Ligand for the Tandem GAF Domain of Human Phosphodiesterase 10 and cGMP for the Tandem GAF Domain of Phosphodiesterase 11 J. Biol. Chem., February 3, 2006; 281(5): 2841 - 2846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Seybold, D. Thomas, M. Witzenrath, S. Boral, A. C. Hocke, A. Burger, A. Hatzelmann, H. Tenor, C. Schudt, M. Krull, et al. Tumor necrosis factor-{alpha}-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability Blood, May 1, 2005; 105(9): 3569 - 3576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhao, H.-T. Zhang, and J. M. O'Donnell Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text]
|
|
|
|
|
|
N. U. Suvarna and J. M. O'Donnell Hydrolysis of N-Methyl-D-aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Jimenez, C. Punzon, J. Navarro, M. A. Munoz-Fernandez, and M. Fresno Phosphodiesterase 4 Inhibitors Prevent Cytokine Secretion by T Lymphocytes by Inhibiting Nuclear Factor-kappa B and Nuclear Factor of Activated T Cells Activation J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 753 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sato, W. Zhao, and G. J. Christ Central modulation of the NO/cGMP pathway affects the MPOA-induced intracavernous pressure response Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R269 - R278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hatzelmann and C. Schudt Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 267 - 279. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Hetman, N. Robas, R. Baxendale, M. Fidock, S. C. Phillips, S. H. Soderling, and J. A. Beavo Cloning and characterization of two splice variants of human phosphodiesterase 11A PNAS, October 23, 2000; (2000) 200355397. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Yano, M. Kohno, T. Ohkusa, M. Mochizuki, J. Yamada, M. Kohno, T. Hisaoka, K. Ono, T. Tanigawa, S. Kobayashi, et al. Effect of milrinone on left ventricular relaxation and Ca2+ uptake function of cardiac sarcoplasmic reticulum Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1898 - H1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Conti Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells Mol. Endocrinol., September 1, 2000; 14(9): 1317 - 1327. [Full Text]
|
|
|
|
|
|
W. Zhang and R. W. Colman Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding Blood, June 1, 2000; 95(11): 3380 - 3386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Hayashi, R. Morishita, H. Matsushita, H. Nakagami, Y. Taniyama, T. Nakamura, M. Aoki, K. Yamamoto, J. Higaki, and T. Ogihara Cyclic AMP Inhibited Proliferation of Human Aortic Vascular Smooth Muscle Cells, Accompanied by Induction of p53 and p21 Hypertension, January 1, 2000; 35(1): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Baumann, C. Blass, R. Gotz, and S. Dragon Ontogeny of Catecholamine and Adenosine Receptor-Mediated cAMP Signaling of Embryonic Red Blood Cells: Role of cGMP-Inhibited Phosphodiesterase 3 and Hemoglobin Blood, December 15, 1999; 94(12): 4314 - 4320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. Turko, S. H. Francis, and J. D. Corbin Studies of the Molecular Mechanism of Discrimination between cGMP and cAMP in the Allosteric Sites of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5) J. Biol. Chem., October 8, 1999; 274(41): 29038 - 29041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kitamura, Y. Kitamura, S. Kuroda, Y. Hino, M. Ando, K. Kotani, H. Konishi, H. Matsuzaki, U. Kikkawa, W. Ogawa, et al. Insulin-Induced Phosphorylation and Activation of Cyclic Nucleotide Phosphodiesterase 3B by the Serine-Threonine Kinase Akt Mol. Cell. Biol., September 1, 1999; 19(9): 6286 - 6296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gendron*, L. Laflamme*, N. Rivard, C. Asselin, M. D. Payet, and N. Gallo-Payet Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108-15 Cells Mol. Endocrinol., September 1, 1999; 13(9): 1615 - 1626. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Côté, M. D. Payet, E. Rousseau, G. Guillon, and N. Gallo-Payet Comparative Involvement of Cyclic Nucleotide Phosphodiesterases and Adenylyl Cyclase on Adrenocorticotropin-Induced Increase of Cyclic Adenosine Monophosphate in Rat and Human Glomerulosa Cells Endocrinology, August 1, 1999; 140(8): 3594 - 3601. [Abstract] [Full Text]
|
|
|
|
|
|
J. Lim, G. Pahlke, and M. Conti Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation. IDENTIFICATION AND FUNCTION OF AN INHIBITORY DOMAIN J. Biol. Chem., July 9, 1999; 274(28): 19677 - 19685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Méhats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet, F. Ferré, and M. J. Leroy Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture Endocrinology, July 1, 1999; 140(7): 3228 - 3237. [Abstract] [Full Text]
|
|
|
|
|
|
K. Fujishige, J. Kotera, H. Michibata, K. Yuasa, S.-i. Takebayashi, K. Okumura, and K. Omori Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A) J. Biol. Chem., June 25, 1999; 274(26): 18438 - 18445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Corbin and S. H. Francis Cyclic GMP Phosphodiesterase-5: Target of Sildenafil J. Biol. Chem., May 14, 1999; 274(20): 13729 - 13732. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, R. Terwilliger, C. Lane, P. S. Mezes, M. Conti, and R. S. Duman Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms J. Neurosci., January 15, 1999; 19(2): 610 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Wright, J. Seybold, A. Robichaud, I. M. Adcock, and P. J. Barnes Phosphodiesterase expression in human epithelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L694 - L700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Seybold, R. Newton, L. Wright, P. A. Finney, N. Suttorp, P. J. Barnes, I. M. Adcock, and M. A. Giembycz Induction of Phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in Human Peripheral Blood T-lymphocytes by 8-Bromo-cAMP and Gs-coupled Receptor Agonists. POTENTIAL ROLE IN beta 2-ADRENORECEPTOR DESENSITIZATION J. Biol. Chem., August 7, 1998; 273(32): 20575 - 20588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Moore, P. M. Chetham, J. J. Kelly, and T. Stevens Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L203 - L222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Soderling, S. J. Bayuga, and J. A. Beavo Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases J. Biol. Chem., June 19, 1998; 273(25): 15553 - 15558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Fisher, J. F. Smith, J. S. Pillar, S. H. St. Denis, and J. B. Cheng Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase J. Biol. Chem., June 19, 1998; 273(25): 15559 - 15564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Navarro, C. Punzon, J. L. Jimenez, E. Fernandez-Cruz, A. Pizarro, M. Fresno, and M. A. Munoz-Fernandez Inhibition of Phosphodiesterase Type IV Suppresses Human Immunodeficiency Virus Type 1 Replication and Cytokine Production in Primary T Cells: Involvement of NF-kappa B and NFAT J. Virol., June 1, 1998; 72(6): 4712 - 4720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Murthy and G. M. Makhlouf cGMP-mediated Ca2+ release from IP3-insensitive Ca2+ stores in smooth muscle Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1199 - C1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wexler, P. K. Stanton, and S. Nawy Nitric Oxide Depresses GABAA Receptor Function via Coactivation of cGMP-Dependent Kinase and Phosphodiesterase J. Neurosci., April 1, 1998; 18(7): 2342 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. MacKenzie, S. J. Yarwood, A. H. Peden, G. B. Bolger, R. G. Vernon, and M. D. Houslay Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes PNAS, March 31, 1998; 95(7): 3549 - 3554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. Turko, S. H. Francis, and J. D. Corbin Potential Roles of Conserved Amino Acids in the Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5) J. Biol. Chem., March 13, 1998; 273(11): 6460 - 6466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Wyatt, A. J. Naftilan, S. H. Francis, and J. D. Corbin ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H448 - H455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Iona, M. Cuomo, T. Bushnik, F. Naro, C. Sette, M. Hess, E. R. Shelton, and M. Conti Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain Mol. Pharmacol., January 1, 1998; 53(1): 23 - 32. [Abstract] [Full Text]
|
|
|
|
|
|
A. Lochhead, E. Nekrasova, V. Y. Arshavsky, and N. J. Pyne The Regulation of the cGMP-binding cGMP Phosphodiesterase by Proteins That Are Immunologically Related to gamma Subunit of the Photoreceptor cGMP Phosphodiesterase J. Biol. Chem., July 18, 1997; 272(29): 18397 - 18403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Essayan, A. Kagey-Sobotka, L. M. Lichtenstein, and S.-K. Huang Differential Regulation of Human Antigen-Specific Th1 and Th2 Lymphocyte Responses by Isozyme Selective Cyclic Nucleotide Phosphodiesterase Inhibitors J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 505 - 512. [Abstract] [Full Text]
|
|
|
|
|
|
S. Jacobitz, M. D. Ryan, M. M. McLaughlin, G. P. Livi, W. E. Dewolf Jr., and T. J. Torphy Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A Mol. Pharmacol., June 1, 1997; 51(6): 999 - 1006. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Dell'Acqua and J. D. Scott Protein Kinase A Anchoring J. Biol. Chem., May 16, 1997; 272(20): 12881 - 12884. [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Yu, L.-M. Hung, and C.-C. Lin cGMP-Elevating Agents Suppress Proliferation of Vascular Smooth Muscle Cells by Inhibiting the Activation of Epidermal Growth Factor Signaling Pathway Circulation, March 4, 1997; 95(5): 1269 - 1277. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. Cheng, J. W. Watson, C. J. Pazoles, J. D. Eskra, R. J. Griffiths, V. L. Cohan, C. R. Turner, H. J. Showell, and E. R. Pettipher The Phosphodiesterase Type 4 (PDE4) Inhibitor CP-80,633 Elevates Plasma Cyclic AMP Levels and Decreases Tumor Necrosis Factor-alpha (TNFalpha ) Production in Mice: Effect of Adrenalectomy J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 621 - 626. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. J. TORPHY Phosphodiesterase Isozymes . Molecular Targets for Novel Antiasthma Agents Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 351 - 370. [Full Text]
|
|
|
|
|
|
G. A. Omburo, T. J. Torphy, G. Scott, S. Jacobitz, R. F. Colman, and R. W. Colman Inactivation of Recombinant Monocyte cAMP-Specific Phosphodiesterase by cAMP Analog, 8-[(4-Bromo-2,3-Dioxobutyl)thio]Adenosine 3',5'-Cyclic Monophosphate Blood, February 1, 1997; 89(3): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Huston, L. Pooley, P. Julien, G. Scotland, I. McPhee, M. Sullivan, G. Bolger, and M. D. Houslay The Human Cyclic AMP-specific Phosphodiesterase PDE-46 (HSPDE4A4B) Expressed in Transfected COS7 Cells Occurs as Both Particulate and Cytosolic Species That Exhibit Distinct Kinetics of Inhibition by the Antidepressant Rolipram J. Biol. Chem., December 6, 1996; 271(49): 31334 - 31344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yan, A. Z. Zhao, J. K. Bentley, and J. A. Beavo The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner J. Biol. Chem., October 11, 1996; 271(41): 25699 - 25706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. Turko, T. L. Haik, L. M. McAllister-Lucas, F. Burns, S. H. Francis, and J. D. Corbin Identification of Key Amino Acids in a Conserved cGMP-binding Site of cGMP-binding Phosphodiesterases. A PUTATIVE NKXnD MOTIF FOR cGMP BINDING J. Biol. Chem., September 6, 1996; 271(36): 22240 - 22244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Natochin and N. O. Artemyev An Interface of Interaction between Photoreceptor cGMP Phosphodiesterase Catalytic Subunits and Inhibitory gamma Subunits J. Biol. Chem., August 16, 1996; 271(33): 19964 - 19969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sette and M. Conti Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase. INVOLVEMENT OF SERINE 54IN THE ENZYME ACTIVATION J. Biol. Chem., July 12, 1996; 271(28): 16526 - 16534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Smith, G. Scotland, J. Beattie, I. P. Trayer, and M. D. Houslay Determination of the Structure of the N-terminal Splice Region of the Cyclic AMP-specific Phosphodiesterase RD1 (RNPDE4A1) by 1H NMR and Identification of the Membrane Association Domain Using Chimeric Constructs J. Biol. Chem., July 12, 1996; 271(28): 16703 - 16711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Han, L. Kobzik, J.-L. Balligand, R.A. Kelly, and T.W. Smith Nitric Oxide Synthase (NOS3)–Mediated Cholinergic Modulation of Ca2+ Current in Adult Rabbit Atrioventricular Nodal Cells Circ. Res., June 1, 1996; 78(6): 998 - 1008. [Abstract] [Full Text]
|
|
|
|
|
|
T. Rahn, L. Rönnstrand, M.-J. Leroy, C. Wernstedt, H. Tornqvist, V. C. Manganiello, P. Belfrage, and E. Degerman Identification of the Site in the cGMP-inhibited Phosphodiesterase Phosphorylated in Adipocytes in Response to Insulin and Isoproterenol J. Biol. Chem., May 10, 1996; 271(19): 11575 - 11580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Bolger, I. McPhee, and M. D. Houslay Alternative Splicing of cAMP-specific Phosphodiesterase mRNA Transcripts J. Biol. Chem., January 12, 1996; 271(2): 1065 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Torphy, H.-L. Zhou, J. J. Foley, H. M. Sarau, C. D. Manning, and M. S. Barnette Salbutamol Up-regulates PDE4 Activity and Induces a Heterologous Desensitization of U937 Cells to Prostaglandin E(2) J. Biol. Chem., October 6, 1995; 270(40): 23598 - 23604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. He, A. B. Seryshev, C. W. Cowan, and T. G. Wensel Multiple Zinc Binding Sites in Retinal Rod cGMP Phosphodiesterase, PDE6alpha beta J. Biol. Chem., June 30, 2000; 275(27): 20572 - 20577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yuasa, J. Kotera, K. Fujishige, H. Michibata, T. Sasaki, and K. Omori Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression J. Biol. Chem., September 29, 2000; 275(40): 31469 - 31479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fawcett, R. Baxendale, P. Stacey, C. McGrouther, I. Harrow, S. Soderling, J. Hetman, J. A. Beavo, and S. C. Phillips Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A PNAS, March 28, 2000; 97(7): 3702 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hetman, N. Robas, R. Baxendale, M. Fidock, S. C. Phillips, S. H. Soderling, and J. A. Beavo Cloning and characterization of two splice variants of human phosphodiesterase 11A PNAS, November 7, 2000; 97(23): 12891 - 12895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Kwan, Y. Huang, S. K. Kong, and X. Yao cGMP abolishes agonist-induced [Ca2+]i oscillations in human bladder epithelial cells Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1067 - F1074. [Abstract] [Full Text] [PDF]
|
|
